Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedA new page revision (v3.6.3) is added to the history, replacing the previous revision (v3.6.2). This indicates a software/record update applied to the page.SummaryDifference0.0%

- Check17 days agoChange DetectedA new revision entry v3.6.2 was added to the page history, and the older v3.6.0 entry was removed. This represents a software update to the site without altering study content or data on the page.SummaryDifference0.0%

- Check31 days agoChange DetectedThe study's recruitment status was updated to No longer looking for participants, indicating recruitment has ceased. A new Revision: v3.6.0 entry has been added, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check38 days agoChange DetectedA new revision entry, v3.5.5, was added to the Study Record History, replacing the previous v3.5.4. This reflects an administrative update to the page rather than changes to the trial data.SummaryDifference0.0%

- Check59 days agoChange DetectedNew site revision tag appears: Revision: v3.5.4 has been added, replacing Revision: v3.5.3. This indicates a routine upgrade to the site's underlying version.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page’s displayed interface revision/version is updated from v3.5.2 to v3.5.3, indicating a system release on ClinicalTrials.gov rather than a change to the trial’s record history.SummaryDifference0.0%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.